Eisai Co., Ltd. (ADR)
General ticker "ESAIY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $8.3B (TTM average)
Eisai Co., Ltd. (ADR) does not follow the US Stock Market performance with the rate: -5.2%.
Estimated limits based on current volatility of 1.4%: low 8.11$, high 8.33$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2026-09-30, amount 0.10$ (Y2.47%)
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [5.56$, 9.61$]
- 2027-03-31 to 2028-03-30 estimated range: [5.65$, 9.76$]
Financial Metrics affecting the ESAIY estimates:
- Positive: with PPE of 33.0 at the end of fiscal year the price was neutral
- Positive: 4.06 < Operating profit margin, % of 5.35
- Negative: Industry operating cash flow per share per price (median), % of -0.49 <= 0.01
- Positive: -21.29 < Industry operating profit margin (median), % of -11.80
- Positive: Industry inventory ratio change (median), % of 0.93 <= 1.05
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 4.62 < Operating cash flow per share per price, % of 4.75
Short-term ESAIY quotes
Long-term ESAIY plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | ¥741,751.00MM | ¥789,400.00MM | ¥825,378.00MM |
| Operating Expenses | ¥688,343.00MM | ¥735,022.00MM | ¥781,239.00MM |
| Operating Income | ¥53,408.00MM | ¥54,378.00MM | ¥44,139.00MM |
| Non-Operating Income | ¥8,415.00MM | ¥6,687.00MM | ¥6,860.00MM |
| Interest Expense | ¥2,388.00MM | ¥3,519.00MM | ¥5,656.74MM |
| R&D Expense | ¥169,021.00MM | ¥171,633.00MM | ¥168,230.56MM |
| Income(Loss) | ¥61,823.00MM | ¥61,065.00MM | ¥50,999.00MM |
| Taxes | ¥18,040.00MM | ¥13,007.00MM | ¥10,478.00MM |
| Net Income(Loss)* | ¥42,407.00MM | ¥46,433.00MM | ¥38,558.00MM |
| Stockholders Equity | ¥875,614.00MM | ¥841,417.00MM | ¥902,891.08MM |
| Inventory | ¥174,651.00MM | ¥215,905.00MM | ¥258,664.02MM |
| Assets | ¥1,393,799.00MM | ¥1,386,547.00MM | ¥1,455,398.05MM |
| Operating Cash Flow | ¥55,993.00MM | ¥30,117.00MM | ¥65,021.26MM |
| Capital expenditure | ¥24,823.00MM | ¥22,969.00MM | ¥16,285.27MM |
| Investing Cash Flow | ¥-25,321.00MM | ¥-10,097.00MM | ¥-44,315.57MM |
| Financing Cash Flow | ¥-22,720.00MM | ¥-57,809.00MM | ¥-64,784.81MM |
| Earnings Per Share** | ¥36.97 | ¥40.94 | ¥34.20 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.